{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T08:34:25Z","timestamp":1789893265642,"version":"4.0.1"},"reference-count":327,"publisher":"SAGE Publications","issue":"2_suppl","license":[{"start":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100009009","name":"Novartis Pharmaceuticals Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Cutan Med Surg"],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The treat-to-target (T2T) strategy has become established in several medical specialties as a key guidance to optimal therapeutic decision making. T2T may be effective in the assessment of the biologic class of agents called interleukin (IL)-17 inhibitors, which are emerging as a safe and effective treatment option for autoimmune inflammatory conditions such as plaque psoriasis, psoriatic arthritis (PsA), and ankylosing spondylitis (AS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The objective of this article is to use a T2T approach for the evaluation of the effectiveness and safety of IL-17 inhibitors in the management of patients with plaque psoriasis, PsA, and AS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Following a comprehensive literature search, a full-day meeting was convened to discuss and identify the T2T targets for psoriasis, PsA, and AS. Clinical trial evidence was presented for the approved IL-17 inhibitors\u2014secukinumab, ixekizumab, and brodalumab\u2014to assess whether these data meet T2T safety and efficacy targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>All 3 approved agents were significantly superior to placebo and active controls in the achievement of T2T targets for psoriasis. Secukinumab and ixekizumab were likewise associated with significantly better outcomes than controls in the PsA targets, and secukinumab resulted in significant AS target improvements vs placebo. The IL-17 inhibitors were also associated with low rates of serious adverse events and exacerbations of common comorbid conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Phase III trial results support the T2T benefit and safety of IL-17 inhibitors according to their specific indications for the management of patients with plaque psoriasis, PsA, and AS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1203475418824565","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T17:29:14Z","timestamp":1549906154000},"page":"3S-34S","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Treating to Target(s) With Interleukin-17 Inhibitors"],"prefix":"10.1177","volume":"23","author":[{"given":"Charles W.","family":"Lynde","sequence":"first","affiliation":[{"name":"University of Toronto, ON, Canada"},{"name":"University Health Network, Toronto, ON, Canada"},{"name":"Probity Medical Research, Markham, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Beecker","sequence":"additional","affiliation":[{"name":"The Ottawa Hospital, ON, Canada"},{"name":"The University of Ottawa, ON, Canada"},{"name":"Probity Medical Research, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Dutz","sequence":"additional","affiliation":[{"name":"University of British Columbia, Vancouver, BC, Canada"},{"name":"BC Children\u2019s Hospital Research Institute, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Flanagan","sequence":"additional","affiliation":[{"name":"University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn C.","family":"Guenther","sequence":"additional","affiliation":[{"name":"Western University, London, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Gulliver","sequence":"additional","affiliation":[{"name":"Memorial University of Newfoundland, St. John\u2019s, NL, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Papp","sequence":"additional","affiliation":[{"name":"Probity Medical Research, Waterloo, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Proton","family":"Rahman","sequence":"additional","affiliation":[{"name":"Memorial University of Newfoundland, St. John\u2019s, NL, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalton","family":"Sholter","sequence":"additional","affiliation":[{"name":"University of Alberta, Edmonton, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon E.","family":"Searles","sequence":"additional","affiliation":[{"name":"University of Alberta, Edmonton, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2019,2,11]]},"reference":[{"key":"bibr1-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.339"},{"key":"bibr2-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.10.062"},{"key":"bibr3-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2014.02.012"},{"key":"bibr4-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22528"},{"issue":"10","key":"bibr5-1203475418824565","volume":"21","author":"Korman NJ","year":"2015","journal-title":"Dermatol Online\u2009J"},{"key":"bibr6-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04000.x"},{"key":"bibr7-1203475418824565","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0764"},{"key":"bibr8-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70112-X"},{"key":"bibr9-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1177\/104973202129119874"},{"key":"bibr10-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15375"},{"issue":"2","key":"bibr11-1203475418824565","first-page":"125","volume":"97","author":"Rosen J","year":"2016","journal-title":"Cutis"},{"key":"bibr12-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.508"},{"key":"bibr13-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.3605"},{"issue":"3","key":"bibr14-1203475418824565","first-page":"280","volume":"137","author":"Krueger G","year":"2001","journal-title":"Arch Dermatol"},{"key":"bibr15-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.530"},{"issue":"8","key":"bibr16-1203475418824565","first-page":"891","volume":"146","author":"Kurd SK","year":"2010","journal-title":"Arch Dermatol"},{"issue":"5","key":"bibr17-1203475418824565","first-page":"1247","volume":"27","author":"Shbeeb M","year":"2000","journal-title":"J\u2009Rheumatol"},{"key":"bibr18-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2015.07.001"},{"key":"bibr19-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes324"},{"key":"bibr20-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.03.046"},{"key":"bibr21-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.07.023"},{"key":"bibr22-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1080\/00015550252948130"},{"key":"bibr23-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201706"},{"key":"bibr24-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1002\/art.24608"},{"key":"bibr25-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03565.x"},{"key":"bibr26-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket387"},{"key":"bibr27-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e318294457f"},{"key":"bibr28-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/30.4.245"},{"issue":"238","key":"bibr29-1203475418824565","first-page":"127","volume":"62","author":"Gladman DD","year":"1987","journal-title":"Q J Med"},{"key":"bibr30-1203475418824565","first-page":"ii14","volume":"64","author":"Gladman D","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"bibr31-1203475418824565","doi-asserted-by":"publisher","DOI":"10.5114\/pdia.2013.34161"},{"key":"bibr32-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket435"},{"key":"bibr33-1203475418824565","first-page":"2003","volume-title":"Harrison\u2019s Principles of Internal Medicine","author":"Schur PH","year":"2001","edition":"15"},{"key":"bibr34-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211433"},{"key":"bibr35-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1186\/1478-6354-13-S1-S4"},{"key":"bibr36-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1145-4"},{"key":"bibr37-1203475418824565","first-page":"563","volume":"8","author":"Truong B","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"bibr38-1203475418824565","first-page":"2","volume":"37","author":"El-Gabalawy H","year":"2010","journal-title":"J\u2009Rheumatol"},{"key":"bibr39-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker013"},{"key":"bibr40-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.10100426"},{"key":"bibr41-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.suppl_3.iii8"},{"key":"bibr42-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314258"},{"key":"bibr43-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.05.013"},{"key":"bibr44-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512711"},{"key":"bibr45-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60125-8"},{"key":"bibr46-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14493"},{"key":"bibr47-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503824"},{"key":"bibr48-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)61134-5"},{"key":"bibr49-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-eular.2276"},{"issue":"6","key":"bibr50-1203475418824565","first-page":"890","volume":"77","author":"Mease P","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"bibr51-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23537"},{"issue":"1","key":"bibr52-1203475418824565","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/annrheumdis-2016-209709","volume":"76","author":"Mease PJ","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"bibr53-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31429-0"},{"key":"bibr54-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315231"},{"key":"bibr55-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505066"},{"key":"bibr56-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1490-y"},{"key":"bibr57-1203475418824565","unstructured":"Novartis Pharmaceuticals Canada Inc. Cosentyx\n                      \u00ae\n                      (secukinumab) Product Monograph. Date of approval: May 11, 2018."},{"key":"bibr58-1203475418824565","unstructured":"Eli Lilly Canada Inc. Taltz\u2122 (ixekizumab) Product Monograph. Date of approval: September\u200928, 2018."},{"key":"bibr59-1203475418824565","unstructured":"Valeant Canada LP. Siliq\u2122 (brodalumab) Product Monograph. Date of approval: March 6, 2018."},{"key":"bibr60-1203475418824565","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2014.13151"},{"issue":"4","key":"bibr61-1203475418824565","first-page":"S2","volume":"30","author":"Smolen JS.","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"bibr62-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.123919"},{"key":"bibr63-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.146662"},{"key":"bibr64-1203475418824565","first-page":"S50","volume":"30","author":"Castrej\u00f3n I","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"bibr65-1203475418824565","first-page":"629","volume":"69","author":"Atar D","year":"2010","journal-title":"BMJ"},{"issue":"2","key":"bibr66-1203475418824565","first-page":"104","volume":"69","author":"Castrej\u00f3n I","year":"2011","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"bibr67-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207524"},{"key":"bibr68-1203475418824565","doi-asserted-by":"publisher","DOI":"10.3310\/hta21710"},{"key":"bibr69-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3191-3"},{"key":"bibr70-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16676-2"},{"key":"bibr71-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00347-5"},{"key":"bibr72-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208337"},{"key":"bibr73-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-017-0648-6"},{"key":"bibr74-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211734"},{"key":"bibr75-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-010-1080-1"},{"key":"bibr76-1203475418824565","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150128"},{"key":"bibr77-1203475418824565","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.161473"},{"issue":"7","key":"bibr78-1203475418824565","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","volume":"136","author":"Mosmann TR","year":"1986","journal-title":"J\u2009Immunol"},{"key":"bibr79-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.07.040189.001045"},{"key":"bibr80-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M207577200"},{"key":"bibr81-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/ni1254"},{"key":"bibr82-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/ni1261"},{"key":"bibr83-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041257"},{"key":"bibr84-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1770"},{"key":"bibr85-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1659"},{"key":"bibr86-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1677"},{"issue":"9","key":"bibr87-1203475418824565","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.4049\/jimmunol.162.9.5317","volume":"162","author":"Itoh M","year":"1999","journal-title":"J\u2009Immunol"},{"key":"bibr88-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.11.1545"},{"key":"bibr89-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.11.1553"},{"key":"bibr90-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.07.035"},{"key":"bibr91-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.01.001"},{"key":"bibr92-1203475418824565","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.9.5948"},{"key":"bibr93-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.08.001"},{"key":"bibr94-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0801631105"},{"key":"bibr95-1203475418824565","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003043"},{"key":"bibr96-1203475418824565","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100123"},{"key":"bibr97-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2007.35"},{"key":"bibr98-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.11.009"},{"key":"bibr99-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/ni1449"},{"key":"bibr100-1203475418824565","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.11.6107"},{"key":"bibr101-1203475418824565","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803039"},{"key":"bibr102-1203475418824565","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.5.3456"},{"key":"bibr103-1203475418824565","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.4.1958"},{"key":"bibr104-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.1.617-621.2005"},{"key":"bibr105-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.6.2593"},{"issue":"1","key":"bibr106-1203475418824565","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4049\/jimmunol.161.1.409","volume":"161","author":"Chabaud M","year":"1998","journal-title":"J\u2009Immunol"},{"key":"bibr107-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.04.024"},{"key":"bibr108-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.222"},{"key":"bibr109-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15892-7"},{"issue":"5","key":"bibr110-1203475418824565","first-page":"1092","volume":"159","author":"Nograles KE","year":"2008","journal-title":"Br J Dermatol"},{"key":"bibr111-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.340"},{"key":"bibr112-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.65"},{"key":"bibr113-1203475418824565","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.12.6621"},{"key":"bibr114-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061308"},{"key":"bibr115-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.12.036"},{"key":"bibr116-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1002\/art.23655"},{"key":"bibr117-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1002\/art.33396"},{"key":"bibr118-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5703"},{"key":"bibr119-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1002\/art.38376"},{"key":"bibr120-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.22326"},{"key":"bibr121-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061775"},{"key":"bibr122-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200316069"},{"issue":"4","key":"bibr123-1203475418824565","first-page":"17","volume":"34","author":"Ulu\u00e7kan \u00d6","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"bibr124-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646774"},{"key":"bibr125-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.199547"},{"key":"bibr126-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1002\/art.30093"},{"key":"bibr127-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.2000.0681"},{"key":"bibr128-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.10.870"},{"key":"bibr129-1203475418824565","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01610"},{"key":"bibr130-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1582-3"},{"key":"bibr131-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206323"},{"key":"bibr132-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2817"},{"key":"bibr133-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1002\/art.38638"},{"key":"bibr134-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket387"},{"key":"bibr135-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1002\/art.34423"},{"key":"bibr136-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1271-6"},{"issue":"123","key":"bibr137-1203475418824565","first-page":"361","volume":"22","author":"Xu YY","year":"2016","journal-title":"Discov Med"},{"issue":"10","key":"bibr138-1203475418824565","first-page":"1542","volume":"18","author":"Mielants H","year":"1991","journal-title":"J\u2009Rheumatol"},{"key":"bibr139-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1422591"},{"key":"bibr140-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-016-0152-x"},{"key":"bibr141-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.04.009"},{"key":"bibr142-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-017-0500-9"},{"key":"bibr143-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1177\/1060028015626545"},{"issue":"3","key":"bibr144-1203475418824565","first-page":"3156","volume":"8","author":"Xiong HZ","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"bibr145-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000583"},{"key":"bibr146-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex452"},{"key":"bibr147-1203475418824565","unstructured":"Novartis Pharmaceuticals Canada Inc. Cosentyx\n                      \u00ae\n                      (secukinumab) Product Monograph. Date of approval: May 11, 2018."},{"key":"bibr148-1203475418824565","unstructured":"Eli Lilly Canada Inc. Taltz\u2122 (ixekizumab) Product Monograph. Date of approval: September 28, 2018."},{"key":"bibr149-1203475418824565","unstructured":"Valeant Canada LP. Siliq\u2122 (brodalumab) Product Monograph. Date of approval: March 6, 2018."},{"key":"bibr150-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4152"},{"key":"bibr151-1203475418824565","unstructured":"Canadian Psoriasis Guidelines Committee. Canadian Guidelines for the Management of Plaque Psoriasis. June 2009. http:\/\/www.dermatology.ca\/dermatologists\/guidelines\/psoriasis. Accessed April 2, 2018."},{"key":"bibr152-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)00910-1"},{"key":"bibr153-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.02.039"},{"key":"bibr154-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.391"},{"key":"bibr155-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08183.x"},{"key":"bibr156-1203475418824565","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/69804"},{"key":"bibr157-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0846.2003.00042.x"},{"key":"bibr158-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1159\/000250839"},{"key":"bibr159-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.04.009"},{"key":"bibr160-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07389.x"},{"key":"bibr161-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.04.012"},{"key":"bibr162-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-013-0384-y"},{"key":"bibr163-1203475418824565","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2013.865009"},{"key":"bibr164-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"bibr165-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/j.1087-0024.2004.09113.x"},{"key":"bibr166-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2710.1998.00181.x"},{"key":"bibr167-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12106"},{"key":"bibr168-1203475418824565","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2833"},{"key":"bibr169-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13139"},{"key":"bibr170-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14788"},{"key":"bibr171-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1159\/000365390"},{"key":"bibr172-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1997.03890470111018"},{"key":"bibr173-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12365600"},{"key":"bibr174-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.9.1221"},{"key":"bibr175-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.10806.x"},{"key":"bibr176-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-010-1080-1"},{"key":"bibr177-1203475418824565","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2014.13151"},{"key":"bibr178-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314258"},{"key":"bibr179-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.05.013"},{"key":"bibr180-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13348"},{"key":"bibr181-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12751"},{"key":"bibr182-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14073"},{"key":"bibr183-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512711"},{"key":"bibr184-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60125-8"},{"key":"bibr185-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13768"},{"key":"bibr186-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13622"},{"key":"bibr187-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14493"},{"key":"bibr188-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503824"},{"key":"bibr189-1203475418824565","volume-title":"Presented at the American Academy of Dermatology Annual Meeting","author":"Papp K"},{"key":"bibr190-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12636"},{"key":"bibr191-1203475418824565","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2013.769042"},{"key":"bibr192-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.03.037"},{"key":"bibr193-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1080\/00015550260132488"},{"key":"bibr194-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14195"},{"key":"bibr195-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1159\/000251595"},{"key":"bibr196-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14237"},{"key":"bibr197-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.07.058"},{"issue":"5","key":"bibr198-1203475418824565","first-page":"S20","volume":"10","author":"Gottlieb A","year":"2017","journal-title":"J\u2009Clin Aesthet Dermatol"},{"key":"bibr199-1203475418824565","unstructured":"Gottlieb AB, Sullivan J, Kubanov A, You R, Regnault P, Frueh J. Secukinumab shows high and sustained efficacy in subjects with moderate to severe palmoplantar psoriasis: 2.5-year results from the GESTURE study. Presented at the 2017 Psoriasis Gene to Clinic Congress. London (UK); November\u200930, 2017. Poster\u2009P026."},{"key":"bibr200-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03364.x"},{"key":"bibr201-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1177\/1203475415573663"},{"key":"bibr202-1203475418824565","volume-title":"Presented at the 23rd World Congress of Dermatology","author":"Reich K"},{"issue":"8","key":"bibr203-1203475418824565","first-page":"821","volume":"14","author":"Gottlieb AB","year":"2015","journal-title":"J\u2009Drugs Dermatol"},{"key":"bibr204-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-eular.5018"},{"key":"bibr205-1203475418824565","first-page":"AB232","volume":"6","author":"Reich K","year":"2017","journal-title":"J\u2009Am Acad Dermatol"},{"key":"bibr206-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14033"},{"key":"bibr207-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.06.080"},{"issue":"6","key":"bibr208-1203475418824565","first-page":"396","volume":"49","author":"Farber EM","year":"1992","journal-title":"Cutis"},{"key":"bibr209-1203475418824565","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200102030-00005"},{"key":"bibr210-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1159\/000018026"},{"key":"bibr211-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03372.x"},{"key":"bibr212-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.05.033"},{"key":"bibr213-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1329502"},{"key":"bibr214-1203475418824565","unstructured":"Novartis Pharmaceuticals Canada Inc. Cosentyx\n                      \u00ae\n                      (secukinumab) Product Monograph. Date of approval: May 11, 2018."},{"key":"bibr215-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2016.1249820"},{"key":"bibr216-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.01.032"},{"key":"bibr217-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13306"},{"key":"bibr218-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13622"},{"key":"bibr219-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14702"},{"key":"bibr220-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1002\/art.21972"},{"key":"bibr221-1203475418824565","volume-title":"Presented at the 2015 Annual Meeting of the American College of Rheumatology","author":"GRAPPA"},{"key":"bibr222-1203475418824565","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130163"},{"key":"bibr223-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23174"},{"key":"bibr224-1203475418824565","first-page":"S3","volume":"27","author":"Benedek TG.","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"bibr225-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.133645"},{"key":"bibr226-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1002\/art.40391"},{"key":"bibr227-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken059"},{"key":"bibr228-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780241012"},{"key":"bibr229-1203475418824565","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.161473"},{"key":"bibr230-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211734"},{"key":"bibr231-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.102053"},{"key":"bibr232-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex183"},{"key":"bibr233-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00347-5"},{"key":"bibr234-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.129379"},{"key":"bibr235-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201341"},{"key":"bibr236-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208617"},{"key":"bibr237-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.122259"},{"key":"bibr238-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-015-0522-3"},{"key":"bibr239-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.094870"},{"key":"bibr240-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213184"},{"key":"bibr241-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3814-2"},{"key":"bibr242-1203475418824565","unstructured":"Molto A, Dougados M. Treat to Target Trial in Axial Spondylo Arthritis: The TICOSPA (Tight Control in Spondyloarthritis) (TICOSPA). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03043846. Published February 6, 2017. Accessed May 10, 2018."},{"key":"bibr243-1203475418824565","unstructured":"A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine Treatment (STRIKE). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02897115. Published September 12, 2016. Accessed May\u200910, 2018."},{"key":"bibr244-1203475418824565","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110546"},{"key":"bibr245-1203475418824565","first-page":"S95","volume":"44","author":"Pavy S","year":"2001","journal-title":"Arthritis Rheum"},{"key":"bibr246-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)61134-5"},{"key":"bibr247-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-eular.2276"},{"issue":"6","key":"bibr248-1203475418824565","first-page":"890","volume":"77","author":"Mease P","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"bibr249-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex301"},{"key":"bibr250-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23537"},{"issue":"1","key":"bibr251-1203475418824565","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/annrheumdis-2016-209709","volume":"76","author":"Mease PJ","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"bibr252-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31429-0"},{"key":"bibr253-1203475418824565","volume-title":"Presented at the 2017 ACR\/ARHP Annual Meeting","author":"Helliwell PS"},{"key":"bibr254-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315231"},{"key":"bibr255-1203475418824565","unstructured":"UCB. Press release: Bimekizumab demonstrates impressive joint and skin responses for psoriatic arthritis patients. https:\/\/www.ucb.com\/stories-media\/Press-Releases\/article\/Bimekizumab-demonstrates-impressive-joint-and-skin-responses-for-psoriatic-arthritis-patients-nbsp. Published December 20, 2017. Accessed May 15, 2018."},{"key":"bibr256-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270401"},{"key":"bibr257-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505066"},{"key":"bibr258-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1490-y"},{"key":"bibr259-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209730"},{"issue":"1","key":"bibr260-1203475418824565","first-page":"50","volume":"36","author":"Baraliakos X","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"bibr261-1203475418824565","volume-title":"Presented at the 2017\u2009ACR\/ARHP Annual Meeting","author":"Braun J"},{"key":"bibr262-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23233"},{"key":"bibr263-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000592"},{"key":"bibr264-1203475418824565","unstructured":"UCB. Press release: Bimekizumab advances with significant results in ankylosing spondylitis patients. Available at: https:\/\/www.ucb.com\/stories-media\/Press-Releases\/article\/Bimekizumab-advances-with-significant-results-in-ankylosing-spondylitis-patients. Published December 14, 2017. Accessed May 15, 2018."},{"key":"bibr265-1203475418824565","unstructured":"Novartis Pharmaceuticals Canada Inc. Cosentyx\n                      \u00ae\n                      (secukinumab) Product Monograph. Date of approval: May 11, 2018."},{"key":"bibr266-1203475418824565","unstructured":"Eli Lilly Canada Inc. Taltz\u2122 (ixekizumab) Product Monograph. Date of approval: September 28, 2018."},{"key":"bibr267-1203475418824565","unstructured":"Valeant Canada LP. Siliq\u2122 (brodalumab) Product Monograph. Date of approval: March 6, 2018."},{"key":"bibr268-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15015"},{"key":"bibr269-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15242."},{"key":"bibr270-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23738."},{"key":"bibr271-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.02.1057"},{"key":"bibr272-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512711"},{"issue":"1","key":"bibr273-1203475418824565","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/annrheumdis-2016-209709","volume":"76","author":"Mease PJ","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"bibr274-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31429-0"},{"key":"bibr275-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14493"},{"key":"bibr276-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503824"},{"key":"bibr277-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412679"},{"issue":"8","key":"bibr278-1203475418824565","first-page":"1609","volume":"207","author":"Cruz A","year":"2010","journal-title":"Mycobacterium tuberculosis. J\u2009Exp Med"},{"key":"bibr279-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004099"},{"key":"bibr280-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2017.34"},{"key":"bibr281-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.06.122"},{"key":"bibr282-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.08.040"},{"key":"bibr283-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03318.x"},{"key":"bibr284-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09593.x"},{"key":"bibr285-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.14.1735"},{"key":"bibr286-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.08.013"},{"key":"bibr287-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.112"},{"key":"bibr288-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.10.012"},{"key":"bibr289-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000306"},{"key":"bibr290-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22926"},{"key":"bibr291-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.094839"},{"issue":"11","key":"bibr292-1203475418824565","first-page":"2167","volume":"33","author":"Han C","year":"2006","journal-title":"J\u2009Rheumatol"},{"key":"bibr293-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2014.10.007"},{"key":"bibr294-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-015-0166-0"},{"key":"bibr295-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14964"},{"key":"bibr296-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.03.024"},{"key":"bibr297-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.09.026"},{"key":"bibr298-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.04.724"},{"key":"bibr299-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.540"},{"key":"bibr300-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.02.015"},{"key":"bibr301-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.03031.x"},{"key":"bibr302-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/22.2.268"},{"key":"bibr303-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202143"},{"issue":"3","key":"bibr304-1203475418824565","first-page":"511","volume":"29","author":"Palm O","year":"2002","journal-title":"J\u2009Rheumatol"},{"key":"bibr305-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03868.x"},{"key":"bibr306-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1736"},{"key":"bibr307-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2003.09.013"},{"key":"bibr308-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301668"},{"key":"bibr309-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.07.084"},{"key":"bibr310-1203475418824565","unstructured":"EU Clinical Trials Register. Clinical trials for bimekizumab ulcerative colitis. https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=bimekizumab+ulcerative+colitis. Accessed July 14, 2018."},{"issue":"6","key":"bibr311-1203475418824565","first-page":"778","volume":"137","author":"Margolis D","year":"2001","journal-title":"Arch Dermatol"},{"key":"bibr312-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13619"},{"key":"bibr313-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.05.021"},{"key":"bibr314-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700410"},{"key":"bibr315-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12165"},{"key":"bibr316-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-7310(14)70017-1"},{"key":"bibr317-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/nri2742"},{"key":"bibr318-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315231"},{"issue":"8","key":"bibr319-1203475418824565","first-page":"891","volume":"146","author":"Kurd SK","year":"2010","journal-title":"Arch Dermatol"},{"key":"bibr320-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.508"},{"key":"bibr321-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.530"},{"key":"bibr322-1203475418824565","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130797"},{"key":"bibr323-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.11.032"},{"key":"bibr324-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-014-0418-z"},{"key":"bibr325-1203475418824565","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.08.024"},{"key":"bibr326-1203475418824565","unstructured":"Valeant Pharmaceuticals North America. SILIQ (brodalumab) prescribing information. February\u20092017."},{"key":"bibr327-1203475418824565","unstructured":"European Medicines Agency. Kyntheum (INN-brodalumab) summary of product characteristics. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/003959\/WC500232913.pdf. Published July 17, 2017. Accessed June 21, 2018."}],"container-title":["Journal of Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1203475418824565","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1203475418824565","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1203475418824565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:54:14Z","timestamp":1777391654000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1203475418824565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,11]]},"references-count":327,"journal-issue":{"issue":"2_suppl","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.1177\/1203475418824565"],"URL":"https:\/\/doi.org\/10.1177\/1203475418824565","relation":{},"ISSN":["1203-4754","1615-7109"],"issn-type":[{"value":"1203-4754","type":"print"},{"value":"1615-7109","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,11]]}}}